AssayQuant Technologies Inc. is a leading life science company based in Marlborough, MA, dedicated to supporting the development of more effective therapies for serious conditions such as cancer, chronic inflammation, and neurodegeneration. With their proprietary PhosphoSens Technology, AssayQuant offers a powerful approach for understanding kinase and phosphatase function, enabling the identification of the most effective drugs. Their direct, real-time, kinetic, enzyme activity assays provide better data and enable faster movement through the drug discovery process.
AssayQuant's catalog of over four hundred optimized assays, developed from curated libraries of fluorogenic peptide sensor substrates, allows for rapid ranking of candidates by inhibition mechanism, selectivity profiling, and potency measures. In addition to their catalog kits and bulk reagents, AssayQuant also provides assay development services and compound testing services. Committed to innovation, AssayQuant is driven by a shared vision of reducing suffering and building a healthier world.
Generated from the website